Literature DB >> 11756503

Short-term retrograde inhibition of GABAergic synaptic currents in rat Purkinje cells is mediated by endogenous cannabinoids.

Marco A Diana1, Carole Levenes, Ken Mackie, Alain Marty.   

Abstract

Depolarization-induced suppression of inhibition (DSI) is a form of short-term plasticity of GABAergic synaptic transmission that is found in cerebellar Purkinje cells and hippocampal CA1 pyramidal cells. DSI involves the release of a calcium-dependent retrograde messenger by the somatodendritic compartment of the postsynaptic cell. Both glutamate and endogenous cannabinoids have been proposed as retrograde messenger. Here we show that, in cerebellar parasagittal slices, type 1 cannabinoid receptors (CB1Rs) are expressed at high levels in axons of GABAergic interneurons and in presynaptic terminals onto Purkinje cells. Application of the cannabinoid antagonist AM-251 (500 nm) leads to the abolition of the DSI of evoked currents (eIPSCs) recorded in paired recordings and to a strong reduction of the DSI of TTX-insensitive miniature events (mIPSCs) recorded from Purkinje cells. Furthermore, the CB1R agonist WIN 55-212,2 (5 microm) induces a presynaptic inhibition of synaptic currents similar to that occurring during DSI, as well as an occlusion of DSI after stimulation of Purkinje cells. Moreover, WIN 55-212,2 reduces the calcium transients evoked in presumed presynaptic varicosities by short trains of action potentials. Our results indicate that DSI is mediated by the activation of presynaptic CB1Rs and that an endogenous cannabinoid is a likely candidate retrograde messenger in this preparation. They further suggest that DSI involves distinct presynaptic modifications for eIPSCs and mIPSCs, including an inhibition of action potential-evoked calcium rises.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11756503      PMCID: PMC6757612     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  47 in total

1.  Dendritic release of glutamate suppresses synaptic inhibition of pyramidal neurons in rat neocortex.

Authors:  Y Zilberter
Journal:  J Physiol       Date:  2000-11-01       Impact factor: 5.182

2.  Photolysis-induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons.

Authors:  J Wang; R S Zucker
Journal:  J Physiol       Date:  2001-06-15       Impact factor: 5.182

3.  Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system.

Authors:  K Tsou; S Brown; M C Sañudo-Peña; K Mackie; J M Walker
Journal:  Neuroscience       Date:  1998-03       Impact factor: 3.590

4.  The Cav2.1/alpha1A (P/Q-type) voltage-dependent calcium channel mediates inhibitory neurotransmission onto mouse cerebellar Purkinje cells.

Authors:  G J Stephens; N P Morris; R E Fyffe; B Robertson
Journal:  Eur J Neurosci       Date:  2001-05       Impact factor: 3.386

5.  Localization of cannabinoid receptor mRNA in rat brain.

Authors:  L A Matsuda; T I Bonner; S J Lolait
Journal:  J Comp Neurol       Date:  1993-01-22       Impact factor: 3.215

6.  Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons.

Authors:  W Twitchell; S Brown; K Mackie
Journal:  J Neurophysiol       Date:  1997-07       Impact factor: 2.714

7.  Retrograde signalling in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells.

Authors:  B E Alger; T A Pitler; J J Wagner; L A Martin; W Morishita; S A Kirov; R A Lenz
Journal:  J Physiol       Date:  1996-10-01       Impact factor: 5.182

8.  Fluctuations of inhibitory postsynaptic currents in Purkinje cells from rat cerebellar slices.

Authors:  P Vincent; A Marty
Journal:  J Physiol       Date:  1996-07-01       Impact factor: 5.182

Review 9.  Dendritic release of dopamine in the substantia nigra.

Authors:  A Cheramy; V Leviel; J Glowinski
Journal:  Nature       Date:  1981-02-12       Impact factor: 49.962

10.  Role of cyclic AMP dependent protein kinase in cannabinoid receptor modulation of potassium "A-current" in cultured rat hippocampal neurons.

Authors:  R E Hampson; G J Evans; J Mu; S Y Zhuang; V C King; S R Childers; S A Deadwyler
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

View more
  57 in total

1.  Are CB(1) Receptor Antagonists Nootropic or Cognitive Impairing Agents?

Authors:  Stephen A Varvel; Laura E Wise; Aron H Lichtman
Journal:  Drug Dev Res       Date:  2009-12-01       Impact factor: 4.360

2.  Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons.

Authors:  Attila Losonczy; Agota A Biró; Zoltan Nusser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-20       Impact factor: 11.205

3.  Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain.

Authors:  Michiru Hirasawa; Yannick Schwab; Sirajedin Natah; Cecilia J Hillard; Ken Mackie; Keith A Sharkey; Quentin J Pittman
Journal:  J Physiol       Date:  2004-07-14       Impact factor: 5.182

Review 4.  [Cannabinoids--signal transduction and mode of action].

Authors:  R Rukwied; B Gauter; M Schley; C Konrad
Journal:  Schmerz       Date:  2005-11       Impact factor: 1.107

5.  Purine receptor-mediated endocannabinoid production and retrograde synaptic signalling in the cerebellar cortex.

Authors:  Flora E Kovacs; Peter Illes; Bela Szabo
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

6.  Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol.

Authors:  Bela Szabo; Michal J Urbanski; Tiziana Bisogno; Vincenzo Di Marzo; Aitziber Mendiguren; Wolfram U Baer; Ilka Freiman
Journal:  J Physiol       Date:  2006-09-14       Impact factor: 5.182

7.  Central cannabinoid receptors modulate acquisition of eyeblink conditioning.

Authors:  Adam B Steinmetz; John H Freeman
Journal:  Learn Mem       Date:  2010-10-28       Impact factor: 2.460

8.  Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice.

Authors:  S A Varvel; E A Anum; A H Lichtman
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

Review 9.  Activation of G-proteins in brain by endogenous and exogenous cannabinoids.

Authors:  Steven R Childers
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

Review 10.  Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.

Authors:  Mario van der Stelt; Henrik H Hansen; Wouter B Veldhuis; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Johannes F G Vliegenthart; Harald S Hansen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.